|
Status |
Public on Jan 03, 2014 |
Title |
LNCaP.GFP.6 |
Sample type |
RNA |
|
|
Source name |
Prostate cancer cell line
|
Organism |
Homo sapiens |
Characteristics |
cell line: LNCaP overexpression vector: GFP
|
Treatment protocol |
Cells were transfected with 3μM pcDNA3.1_GFP (Control) or 3μM pcDNA3.1_FoxA1 using Lipofectamine2000 (Invitrogen). Cells were harvested 48h later.
|
Growth protocol |
Cells were grown in RPMI + 10% FBS and standard antibiotics in a 37oC incubator with 5% CO2
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted using Qiagen RNEasy with on column DNaseI digestion according the the manufacturer's instructions.Quality control was performed with Agilent Bioanalyser.
|
Label |
Biotin
|
Label protocol |
Biotinylated cRNA were prepared with Ambion MessageAmp kit for Illumina arrays
|
|
|
Hybridization protocol |
Standard Illumina hybridisation procedure
|
Scan protocol |
Standard Illumina scanning procedure
|
Description |
Control (GFP overexpressing) LNCaP prostate cancer cell line replicate 6
|
Data processing |
The data were normalised using quantile normalisation with IlluminaGUI in R
|
|
|
Submission date |
Jul 23, 2013 |
Last update date |
Sep 14, 2015 |
Contact name |
Chandra Chilamakuri |
E-mail(s) |
[email protected]
|
Organization name |
Cancer Research UK Cambridge Institute
|
Street address |
Robinson Way
|
City |
Cambridge |
ZIP/Postal code |
CB2 0RE |
Country |
United Kingdom |
|
|
Platform ID |
GPL10558 |
Series (1) |
GSE49153 |
Effect of FOXA1 overexpression in prostate cancer |
|